Droz JP - Search Results

1

Phase I clinical trial and pharmacokinetic evaluation of doxorubicin carried by polyisohexylcyanoacrylate nanoparticles.

Kattan J, Droz JP, Couvreur P, Marino JP, Boutan-Laroze A, Rougier P, Brault P, Vranckx H, Grognet JM, Morge X, et al. Kattan J, et al. Among authors: droz jp. Invest New Drugs. 1992 Aug;10(3):191-9. doi: 10.1007/BF00877245. Invest New Drugs. 1992. PMID: 1428729 Clinical Trial.

2

Phase II trial of pirarubicin in the treatment of advanced bladder cancer.

Mahjoubi M, Kattan J, Ghosn M, Droz JP, Philippot I, Herait P. Mahjoubi M, et al. Among authors: droz jp. Invest New Drugs. 1992 Nov;10(4):317-21. doi: 10.1007/BF00944188. Invest New Drugs. 1992. PMID: 1487407 Clinical Trial.

3

Phase II trial of LY 186641 in advanced renal cancer.

Mahjoubi M, Kattan J, Bonnay M, Schmitt H, Droz JP. Mahjoubi M, et al. Among authors: droz jp. Invest New Drugs. 1993 Nov;11(4):323-8. doi: 10.1007/BF00874431. Invest New Drugs. 1993. PMID: 7726992 Clinical Trial.

4

Phase I study of retelliptine dihydrochloride (SR 95325 B) using a single two-hour intravenous infusion schedule.

Kattan J, Durand M, Droz JP, Mahjoubi M, Marino JP, Azab M. Kattan J, et al. Among authors: droz jp. Am J Clin Oncol. 1994 Jun;17(3):242-5. doi: 10.1097/00000421-199406000-00013. Am J Clin Oncol. 1994. PMID: 8192111 Clinical Trial.

5

[Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy].

Kattan J, Droz JP, Culine S, Ribrag V, Boutan-Laroze A, Andremont A. Kattan J, et al. Among authors: droz jp. Bull Cancer. 1992;79(7):705-12. Bull Cancer. 1992. PMID: 1467596 French.

6

Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.

Kattan J, Droz JP, Ribrag V, Azab M, Boutan-Laroze A, Andremont A. Kattan J, et al. Among authors: droz jp. Eur J Cancer. 1992;28A(4-5):867-70. doi: 10.1016/0959-8049(92)90136-p. Eur J Cancer. 1992. PMID: 1524911 Clinical Trial.

7

Metastatic carcinoid and islet cell tumours of the pancreas: a phase II trial of the efficacy of combination chemotherapy with 5-fluorouracil, doxorubicin and cisplatin.

Rougier P, Oliveira J, Ducreux M, Theodore C, Kac J, Droz JP. Rougier P, et al. Among authors: droz jp. Eur J Cancer. 1991;27(11):1380-2. doi: 10.1016/0277-5379(91)90014-5. Eur J Cancer. 1991. PMID: 1660291 Clinical Trial.

8

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced carcinoma of the bladder. The French Federation of Cancer Centers experience.

Boutan-Laroze A, Mahjoubi M, Droz JP, Charrot P, Fargeot P, Kerbrat P, Caty A, Voisin PM, Spielmann M, Rey A, et al. Boutan-Laroze A, et al. Among authors: droz jp. Eur J Cancer. 1991;27(12):1690-4. doi: 10.1016/0277-5379(91)90447-l. Eur J Cancer. 1991. PMID: 1782084

9

[Failure of elliptinium acetate in the treatment of unresectable hepatocarcinoma (phase II trial)].

Rougier P, Ychou M, Droz JP. Rougier P, et al. Among authors: droz jp. Bull Cancer. 1988;75(10):979-81. Bull Cancer. 1988. PMID: 2851337 Clinical Trial. French.

10

Phase I trial of high-dose fosfestrol in hormone-refractory adenocarcinoma of the prostate.

Droz JP, De Smedt E, Kattan J, Keuppens F, Khoury S, Mahler C, Denis L. Droz JP, et al. Prostate. 1994;24(2):62-6. doi: 10.1002/pros.2990240203. Prostate. 1994. PMID: 7508621 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

471 results

Search Page

Filters